Amy Goundry

Amy Goundry

Auto-generated profile, based on publicly available information

Amy Goundry

Laboratory of Biochemisty and Molecular Biology of Proteases, Instituto de Biofisica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
TCTatiana F. R. Costa
Tatiana F. R. Costa
AGAmy Goundry
Amy Goundry
AMAlexandre Morrot
Alexandre Morrot
DGDennis Grab
Dennis Grab
JMJeremy C. Mottram
Jeremy C. Mottram
ALAna Paula C. A. Lima
Ana Paula C. A. Lima
The protozoan Trypanosoma brucei rhodesiense causes Human African Trypanosomiasis, also known as sleeping sickness, and penetrates the central nervous system, leading to meningoencephalitis. The Cathepsin L-like cysteine peptidase of T. b. rhodesiense has been implicated in parasite penetration of the blood–brain barrier and its activity is modulated by the chagasin-family endogenous inhibitor of cysteine peptidases (ICP). To investigate the role of ICP in T. b. rhodesiense bloodstream form, ICP-null (Δicp) mutants were generated, and lines re-expressing ICP (Δicp:ICP). Lysates of Δicp displayed increased E-64-sensitive cysteine peptidase activity and the mutant parasites traversed human brain microvascular endothelial cell (HBMEC) monolayers in vitro more efficiently. Δicp induced E-selectin in HBMECs, leading to the adherence of higher numbers of human neutrophils. In C57BL/6 mice, no Δicp parasites could be detected in the blood after 6 days, while mice infected with wild-type (WT) or Δicp:ICP displayed high parasitemia, peaking at day 12. In mice infected with Δicp, there was increased recruitment of monocytes to the site of inoculation and higher levels of IFN-γ in the spleen. At day 14, mice infected with Δicp exhibited higher preservation of the CD4+, CD8+, and CD19+ populations in the spleen, accompanied by sustained high IFN-γ, while NK1.1+ populations receded nearly to the levels of uninfected controls. We propose that ICP helps to downregulate inflammatory responses that contribute to the control of infection.

Verified
Journal Article
Open access
PDF file
PGPollyanna Stephanie Gomes
Pollyanna Stephanie Gomes
MCMonique Pacheco Duarte Carneiro
Monique Pacheco Duarte Carneiro
PMPatrícia de Almeida Machado
Patrícia de Almeida Machado
VAValter Viana Andrade-Neto
Valter Viana Andrade-Neto
AMALESSANDRA MARCIA da FONSECA MARTINS
ALESSANDRA MARCIA da FONSECA MARTINS
HGHerbert L. de Matos Guedes
Herbert L. de Matos Guedes
Subtilisin proteases, found in all organisms, are enzymes important in the post-translational steps of protein processing. In Leishmania major and L. donovani, this enzyme has been described as essential to their survival; however, few compounds that target subtilisin have been investigated for their potential as an antileishmanial drug. In this study, we first show, by electron microscopy and flow cytometry, that subtilisin has broad localization throughout the cytoplasm and membrane of the parasite in the promastigote form with foci in the flagellar pocket. Through in silico analysis, the similarity between subtilisin of different Leishmania species and that of humans were determined, and based on molecular docking, we evaluated the interaction capacity of a serine protease inhibitor against both life cycle forms of Leishmania. The selected inhibitor, known as PF-429242, has already been used against the dengue virus, arenaviruses, and the hepatitis C virus. Moreover, it proved to have antilipogenic activity in a mouse model and caused hypolipidemia in human cells in vitro. Here, PF-429242 significantly inhibited the growth of L. amazonensis promastigotes of four different strains (IC50 values = 3.07 ± 0.20; 0.83 ± 0.12; 2.02 ± 0.27 and 5.83 ± 1.2 µM against LTB0016, PH8, Josefa and LV78 strains) whilst having low toxicity in the host macrophages (CC50 = 170.30 µM). We detected by flow cytometry that there is a greater expression of subtilisin in the amastigote form; however, PF-429242 had a low effect against this intracellular form with an IC50 of >100 µM for intracellular amastigotes, as well as against axenic amastigotes (94.12 ± 2.8 µM for the LV78 strain). In conclusion, even though PF-429242 does not affect the intracellular forms, this drug will serve as a tool to explore pharmacological and potentially leishmanicidal targets.

21 June 2021 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
DLDavid Jessula Levy
David Jessula Levy
AGAmy Goundry
Amy Goundry
RLRaquel S. S. Laires
Raquel S. S. Laires
TCTatiana F. R. Costa
Tatiana F. R. Costa
CNCarlos Mendes Novo
Carlos Mendes Novo
ALAna Paula C. A. Lima
Ana Paula C. A. Lima
Trypanosoma brucei rhodesienseis one of the causative agents of Human African Trypanosomiasis (HAT), known as sleeping sickness. The parasite invades the central nervous system and causes severe encephalitis that is fatal if left untreated. We have previously identified ecotin-like inhibitors of serine peptidases, named ISPs, in trypanosomatid parasitic protozoa. Here, we investigated the role of ISP2 in bloodstream formT.b.rhodesiense. We generated gene-deficient mutants lacking ISP2 (Δisp2), which displayed a growth profilein vitrosimilar to that of wild-type (WT) parasites. C57BL/6 mice infected with Δisp2displayed lower blood parasitemia, a delayed hind leg pathological phenotype and survived longer. The immune response was examined at two time-points that corresponded with two peaks of parasitemia. At 4 days, the spleens of Δisp2-infected mice had a greater percentage of NOS2+myeloid cells, IFN-γ+-NK cells and increased TNF-α compared to those infected with WT and parasites re-expressing ISP2 (Δisp2:ISP2). By 13 days the increased NOS2+population was sustained in Δisp2-infected mice, along with increased percentages of monocyte-derived dendritic cells, as well as CD19+B lymphocytes, and CD8+and CD4+T lymphocytes. Taken together, these findings indicate that ISP2 contributes toT.b.rhodesiensevirulence in mice and attenuates the inflammatory response during early infection.

25 March 2024 in The FASEB Journal
Verified
Journal Article
Closed access
TCTatiana F. R. Costa
Tatiana F. R. Costa
CCCarolina M. C. Catta‐Preta
Carolina M. C. Catta‐Preta
AGAmy Goundry
Amy Goundry
DCDanielle B. Carvalho
Danielle B. Carvalho
NRNathalia S. Rodrigues
Nathalia S. Rodrigues
ALAna Paula C. A. Lima
Ana Paula C. A. Lima

20 January 2026 in Blood & Plasma
Verified
Journal Article
Open access
AGAmy Goundry
Amy Goundry

29 June 2026 in Communications Biology
Verified
Journal Article
Open access
AGAmy Goundry
Amy Goundry
AVAislan C. Vivarini
Aislan C. Vivarini
NRNathalia S. Rodrigues
Nathalia S. Rodrigues
ULUlisses G. Lopes
Ulisses G. Lopes
JMJeremy C. Mottram
Jeremy C. Mottram
ALAna Paula C. A. Lima
Ana Paula C. A. Lima
Leishmania infantum and Leishmania donovani are protozoan parasites that cause visceral leishmaniasis, a potentially fatal disease targeting the liver, spleen and bone marrow. To survive, these parasites manipulate host macrophage microbicidal responses and metabolic pathways. Here, we demonstrate that the host serine proteases neutrophil elastase (NE) and cathepsin G (CG), acting in concert with Toll-like receptors TLR2, TLR3, and TLR4, induce the inflammatory cytokines IFN-α and TNF-α to control L. infantum infection in macrophages. Conversely, in vivo experiments revealed that while NE and CG are necessary for inflammatory responses, including IL-12, nitric oxide, and CCL2 production, they unexpectedly promote splenic parasitism. CG-deficient mice failed to recruit Ly6C hi myeloid cells to the spleen, providing a potential mechanism for their reduced parasite burden. Finally, our data suggest that unlike L. donovani , L. infantum cannot hijack cellular host serine peptidases and TLR signalling for survival, yet it remains dependent on these host enzymes to establish systemic spleen infection.